Search Results
Dr. Yee on Neoadjuvant Pertuzumab in HER2-Positive Breast Cancer
Dr. Yee on Phase II ADAPT Trial Results for HER2+/HR+ Breast Cancer
Neoadjuvant Trastuzumab and Pertuzumab Plus Chemotherapy Versus T-DM1 and Pertuzumab in HER2 Breast
Dr. Tripathy on Neoadjuvant Treatment Strategies in HER2+ Breast Cancer
Dr. Osborne on Pertuzumab in HER2+ Breast Cancer
Breast Cancer: Adding Pertuzumab as a Neoadjuvant Treatment Option
Dr. Peter Beitsch on Pertuzumab in the Luminal Subtype of HER2-Positive Breast Cancer
Dr. Hamilton Discusses Challenges With Approved Treatments for HER2-Positive Breast Cancer
HER2+ Early-Stage Breast Cancer: Peri-Operative Therapy
Dr. Pegram on Pertuzumab and Trastuzumab in Breast Cancer
Dr. Pegram on Challenges in Neoadjuvant Treatment for HER2-Positive Breast Cancer
Dr. Pegram on Pertuzumab Combination for HER2-Positive Breast Cancer
